DUBLIN, July 30, 2020 /PRNewswire/ -- The "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global cell expansion market is projected to reach USD 30.06 billion by 2025 from an estimated USD 14.91 billion in 2020, at a CAGR of 15.1%.
The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users). The report also provides a comprehensive review of market drivers, restraints, and opportunities in the cell expansion market.
Increasing incidence of chronic diseases and government investments for cell-based research are set to drive the cell expansion market
Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.
By instruments type, the cell expansion supporting equipment accounted for the fasted growing product segment of the cell expansion market
The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. The cell expansion supporting equipment market includes flow cytometers, cell counters and hemocytometers, centrifuges, and other supporting equipment. They are used in cell culture processes for isolating, culturing, scaling-up, and extracting biological products. These instruments are essential in laboratories and institutes for conducting research and analyzing the cell structure and function for cell therapy research.
By cell type, the human cells segment accounted for the largest share of the cell expansion market
Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. The human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.
Asia Pacific: The fastest-growing region in the cell expansion market
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the increasing focus of players on emerging Asian markets, increasing incidence of chronic and infectious diseases, rising geriatric population, and government initiatives for infrastructural improvements of healthcare facilities are driving the growth of the cell expansion market in this region.
North America: the largest share of the cell expansion market
North America accounted for the largest share of the cell expansion market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.
Company Profiles
Established Companies
Start-up Companies
For more information about this report visit https://www.researchandmarkets.com/r/5y7cg
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets Laura Wood, Senior Manager [emailprotected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
http://www.researchandmarkets.com
Go here to see the original:
- People are getting costly stem cell injections for knee osteoarthritis, but we don't know if they work - Medical Xpress - April 6th, 2025
- Say goodbye to joint pain without surgery: Expert shares 8 tips on diet plan, lifestyle tweaks, treatments and therapies - Hindustan Times - April 6th, 2025
- Breaking Barriers in Autism: European Wellness Biomedical Group Unveils Bioregenerative Breakthroughs with Prof. Mike Chan -... - April 6th, 2025
- Revolutionizing Success in the Cell Therapy Regenerative - openPR.com - April 4th, 2025
- 5 Best Stem Cell Companies to Invest In (April 2025) - Securities.io - April 4th, 2025
- Boys with cancer can face infertility as adults. Can storing their stem cells help? - Ravalli Republic - April 4th, 2025
- Tip Sheet: Nutrition for People Receiving Stem Cell Transplants, Art Therapy for Cancer Patients, Treating a Rare Type of Colon Cancer and Graduate... - April 4th, 2025
- Human Organoid Market is Set to Revolutionize Drug Discovery and Disease Modeling - openPR.com - April 1st, 2025
- Doctors Told Him He Was Going to Die. Then A.I. Saved His Life. - The New York Times - March 24th, 2025
- Japan team says stem cell treatment helped improve spinal cord injuries | NHK WORLD-JAPAN News - NHK WORLD - March 22nd, 2025
- Boost in cancer treatment: PGI working on lab for stem cell, gene therapies - The Times of India - March 19th, 2025
- Stem Cell Stocks on the Rise: Companies Driving the $48 Billion Market Boom - openPR - March 19th, 2025
- Neuroregeneration Therapy Market Forecasted to Expand at 5.3% CAGR, Reaching USD 64.8 Billion by 2034 - Transparency Market Research, Inc -... - March 19th, 2025
- Cell Therapy Market Surges as Breakthrough Innovations Transform Regenerative Medicine - openPR - March 17th, 2025
- Infinite Health Integrative Medicine Center Fights Chronic Pain with Stem Cell Prolotherapy - PR Newswire - March 14th, 2025
- Stem Cell and Exosome Innovations at Infinite Health Integrative Medicine Center Offers New Hope for Parkinson's Disease - PR Newswire - March 14th, 2025
- Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion - TradingView - March 14th, 2025
- Cell Therapy Market Poised for Exponential Growth, Projected to Reach USD 44.6 Billion by 2034 - openPR - March 14th, 2025
- Trial Repairs Irreversible Corneal Damage With Stem Cell Therapy - Anti Aging News - March 11th, 2025
- Advancing Regenerative Medicine: A Comprehensive Outlook on the Global Cell Therapy Market - openPR - March 7th, 2025
- Top 3 Grants in Regenerative Medicine: February 2025 - RegMedNet - March 7th, 2025
- The future of cell therapy: scaling production for global reach - Drug Target Review - March 7th, 2025
- Stem Cell Therapy Repairs Corneal Damage in Trial - Mirage News - March 7th, 2025
- Autologous Cell Therapy Market Anticipated to Hit USD 12.1 Billion by 2031: Persistence Market Research Study - openPR - March 7th, 2025
- Regenerative Therapies Market Forecast to Reach USD 24.41 Billion by 2033 - Persistence Market Research - openPR - March 5th, 2025
- This Japanese Regenerative Medicine Company Just Secured Its Path to NASDAQ Through a $242M Deal - StockTitan - March 5th, 2025
- Ryoncil, the first FDA-approved mesenchymal stromal cell therapy - Yahoo - March 5th, 2025
- Animal Stem Cell Therapy Market Forecast to Reach USD 437.3 - openPR - March 3rd, 2025
- A Navy SEALs Journey to Stem Cell Treatment: The Future of Medicine is Here, Just Not in America - SOFREP - March 3rd, 2025
- InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug - Forbes - March 3rd, 2025
- VUMC Part of New Study Validating Curative Therapy for Sickle Cell Disease A - Wgnsradio - March 1st, 2025
- Advancing Stem Cell Therapy and Equity in Patient Care - Targeted Oncology - February 27th, 2025
- How Stem Cell Treatment Reversed A Pro Athlete's Life-threatening Long COVID Disease When all Other treatment Failed - Medical Tourism Magazine - February 27th, 2025
- Allogeneic Cell Therapy Market Size to Hit USD 4,677.38 Million by 203 - BioSpace - February 27th, 2025
- Bringing Fibroblasts to the Spotlight: Q&A with FibroBiologics - Pharmaceutical Executive - February 27th, 2025
- Mount Sinai-Led Research Team Identifies Underlying Mechanisms of Age-Related Dysfunction in Glands Crucial to Eye Function | Newswise - Newswise - February 25th, 2025
- Experts explore the future of iPSC-based cell therapies - Drug Target Review - February 19th, 2025
- Longeveron Announces World Health Organization Approval of laromestrocel as International Non-proprietary Name for Stem Cell Therapy Lomecel-B -... - February 19th, 2025
- The impact of cytokines on stem cells and organoid research in drug discovery - News-Medical.Net - February 19th, 2025
- Revolutionary FDA-Approved Stem Cell Partnership Puts Adia Med at Forefront of Regenerative Medicine - StockTitan - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - BioSpace - February 19th, 2025
- Bahrain's pioneering use of sickle cell disease treatment hailed by medical experts - The National - February 19th, 2025
- Uganda Treats First Patient Using Stem Cell Therapy - AllAfrica - Top Africa News - February 19th, 2025
- Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US - StreetInsider.com - February 17th, 2025
- Diversity of Cells Allow Colon Cancer to Resist Treatment and To Metastasize - MedicalResearch.com - February 15th, 2025
- Survival outcomes between haploidentical stem cell transplantation and chemotherapy for blastic plasmacytoid dendritic cell neoplasm - Nature.com - February 13th, 2025
- Experimental cell therapy trial treats first Sjgrens disease patient - University of Wisconsin School of Medicine and Public Health - February 11th, 2025
- Stem Cell Therapy Market Types, Applications, Share, Growth - openPR - February 6th, 2025
- Placental Stem Cell Therapy Solution Market Size And Booming - openPR - February 6th, 2025
- Revitalizing Health with Stem Cell Therapy: A Groundbreaking Path To Longevity and Wellness - openPR - February 4th, 2025
- Gene therapy offers new hope for sickle cell disease patients - Open Access Government - February 4th, 2025
- Scientists trial implant to patch up the heart - BBC.com - February 2nd, 2025
- Cell Therapy Market Size is Projected to Reach USD 33.93 - GlobeNewswire - January 28th, 2025
- Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3 - The Medicine Maker - January 28th, 2025
- Immusoft to Present Positive Data from the First Engineered B Cell in a Human Clinical Trial at the 21st Annual WorldSymposium 2025 - The Eastern... - January 28th, 2025
- Beyond the Lab: Stem cell research - Drug Target Review - January 25th, 2025
- Asia Pacific Stem Cell Therapy Market to Reach US$ 4,075.75 Million by 2033 with a Robust CAGR of 10.29% - openPR - January 25th, 2025
- Exciting data: S.Biomedics preps US IND of PD cell therapy - BioWorld Online - January 25th, 2025
- $24.85 Billion Cell Therapy Market Forecast by 2032 (CAGR 20.4%) - openPR - January 25th, 2025
- Stem Cell Therapy Market Expected to Expand at a Steady 2025-2032 - openPR - January 25th, 2025
- Regenerative Medicine Market to receive overwhelming hike US$ 164.9 billion in Revenues by 2032, Growing at a CAGR of 23.30% From 2024 to 2032 -... - January 25th, 2025
- Alternative medicine fans see RFK Jr. as a hero. The fields skeptics worry. - The Washington Post - January 23rd, 2025
- U.S. PRP and Stem Cell Alopecia Treatment Market Analysis 2025-2030 by Treatment, Indication, and End-use - Androgenic Alopecia Dominated the Market... - January 23rd, 2025
- The Future of Regenerative Medicine Lies in the Hands of Chiropractors - Dynamic Chiropractic - January 23rd, 2025
- Stem Cell Therapy Industry Dynamics and Contributions by RTI - openPR - January 21st, 2025
- Stem Cells Market to Reach USD 44.27 Billion by 2033, Driven by Expanding Applications and Innovations - openPR - January 21st, 2025
- Organoids at the Forefront Innovations in Stem Cell Research and Precision Medicine - openPR - January 21st, 2025
- The promising future of regenerative medicine - Yahoo Finance - January 17th, 2025
- An earful of gill: USC Stem Cell study points to the evolutionary origin of the mammalian outer ear - EurekAlert - January 11th, 2025
- Aspen Partners with Mytos to Automate Stem Cell Production for Parkinsons Therapy - Genetic Engineering & Biotechnology News - January 9th, 2025
- School of Medicine professor receives grant to study improved cancer treatments - Mercer University - January 9th, 2025
- Meet CIRM: the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1 - The Medicine Maker - January 7th, 2025
- Regenerative Medicine Market to Experience Significant Growth, Projected to Reach $183.08 Billion by 2031. - openPR - January 7th, 2025
- Stem-cell therapies that work: 10 Breakthrough Technologies 2025 - MIT Technology Review - January 5th, 2025
- 1st stem cell therapy, new HIV drug approved - ecns - January 5th, 2025
- Science fiction turned reality? Stem cell therapy set to repair child's heart - Ynetnews - January 3rd, 2025
- Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology - The Manila Times - January 1st, 2025
- Allogeneic Stem Cell Transplantation Market Size to Expand Lucratively by 2031 - openPR - January 1st, 2025
- Apoptotic clearance by stem cells: molecular mechanisms for recognition and phagocytosis of dead cells - Nature.com - December 30th, 2024
- Why Medical Tourists are Choosing Mexico: The Affordable Alternative for Advanced Stem Cell Treatments - openPR - December 30th, 2024
Recent Comments